EvokAI Creative Labs Inc. Stock

Equities

OKAI

CA30053J1012

Advanced Medical Equipment & Technology

Delayed Toronto S.E. 09:30:00 2024-04-17 am EDT 5-day change 1st Jan Change
0.13 CAD 0.00% Intraday chart for EvokAI Creative Labs Inc. +8.33% +73.33%
Sales 2021 - Sales 2022 - Capitalization 7.19M 9.89M
Net income 2021 - 0 Net income 2022 - 0 EV / Sales 2021 * -
Net cash position 2021 * - 0 Net cash position 2022 * - 0 EV / Sales 2022 * -
P/E ratio 2021 *
-
P/E ratio 2022 *
-
Employees -
Yield 2021 *
-
Yield 2022 *
-
Free-Float 41.51%
More Fundamentals * Assessed data
Dynamic Chart
EvokAI Creative Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
EvokAI Creative Labs Inc. Receives Ce Mark Approval for Its Mdm Flex Sensor to Transform the Management of Parkinson's Disease CI
EvokAI Creative Labs Inc. completed the acquisition of Rehaboo Oy. CI
EvokAI Creative Labs Closes Acquisition of Extended Reality AI-Powered Company Neurocarrier Oy MT
EvokAI Creative Labs Inc. completed the acquisition of NeuroCarrier Oy. CI
EvokAI Creative Labs Inc. entered into a definitive agreement to acquire NeuroCarrier Oy. CI
EvokAI Creative Labs Inc. completed the acquisition of Head Instruments Oy. CI
EvokAI Creative Labs Inc. entered into a Share Purchase Agreement to acquire Rehaboo Oy for $4 million. CI
EvokAI Creative Labs Inc. Auditor Raises 'Going Concern' Doubt CI
EvokAI Creative Labs Inc. entered into a definitive agreement to acquire Head Instruments Oy for €4.4 million. CI
EvokAI Creative Labs Inc. acquired Sebastiani Ventures Corp. (TSXV:SBS.H) in a reverse merger transaction CI
Sebastiani Ventures Corp. Announces Board Appointments CI
Sebastiani Ventures Corp. Appoints Alejandro Antalich as Chief Executive Officer CI
EvokAI Creative Labs Inc. announced that it has received CAD 5 million in funding from Sebastiani Ventures Corp. CI
Sebastiani Ventures Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
More news
1 week+8.33%
Current month-3.70%
1 month+30.00%
6 months-87.62%
Current year+73.33%
More quotes
1 week
0.13
Extreme 0.13
0.13
1 month
0.12
Extreme 0.12
0.14
Current year
0.08
Extreme 0.08
0.15
1 year
0.08
Extreme 0.075
2.15
3 years
0.08
Extreme 0.075
2.15
5 years
0.08
Extreme 0.075
2.15
10 years
0.08
Extreme 0.075
2.15
More quotes
EvokAI Creative Labs Inc. is a MedTech artificial-intelligence-powered company. It is engaged in the development of transformational technologies for the modern health care sector. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. It offers its AI algorithms across the whole health care system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations to medical professionals, patients, and healthy individuals, aiming at preventing and early detecting any kind of disease and protecting the aging genome. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer and EvokAI Medical. EvokAI Simulators combines cognitive neuroscience, virtual reality and artificial intelligence technologies to assess cognitive performance and spatial perception.
More about the company